Gastric varices: An updated review of management

Journal of Clinical Gastroenterology

Volumn 45, Issue 2, 2011, Pages 133-148

  Irani, Shayan ^a   Kowdley, Kris ^a   Kozarek, Richard ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

esophageal varices; gastric varices; Gastroesophageal varices; management of gastric varices; portal hemodynamics; treatment of gastric varices

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOACRYLATE; ENBUCRILATE; HEMOGLOBIN; IODINATED POPPYSEED OIL; ISOSORBIDE MONONITRATE; PROPRANOLOL; TETRADECYL SULFATE SODIUM; THROMBIN; TISSUE ADHESIVE;

ALGORITHM; ANAPHYLAXIS; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON; BLOOD VOLUME; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG FATALITY; DYSPHAGIA; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC THERAPY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEVER; HEMODYNAMICS; HEMOSTASIS; HUMAN; LIGATION; LIVER CELL CARCINOMA; LIVER FAILURE; MEDIASTINITIS; PLEURA EFFUSION; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SCLEROTHERAPY; SECONDARY PREVENTION; STOMACH PERFORATION; STOMACH ULCER; STOMACH VARICES; STOMACH VARICES BLEEDING; THORAX PAIN;

ALGORITHMS; CYANOACRYLATES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMICS; HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; TISSUE ADHESIVES; TREATMENT OUTCOME;

EID: 78951485710     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181fbe249     Document Type: Article

References (122)

1. Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term followup study in 568 portal hypertension patients. Hepatology. 1992;16:1343-1349.
2. Hashizume M, Sugimachi K. Classification of gastric lesions associated with portal hypertension. J Gastroenterol Hepatol. 1995;10:339-343.
3. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc. 1986;32:264-268.
4. Soehendra N, Nam VC, Grimm H, et al. Endoscopic obliteration of large esophagogastric varices with bucrylate. Endoscopy. 1986;18:25-26.
5. Kind R, Guglielmi A, Rodella L, et al. Bucrylate treatment of bleeding gastric varices: 12 years experience. Endoscopy. 2000;32:512-519.
6. Greig JD, Garden OJ, Anderson JR, et al. Management of gastric variceal haemorrhage. Br J Surg. 1990;77:297-299.
7. Korula J, Chin K, Ko Y, et al. Demonstration of two distinct subsets of gastric varices. Observations during a seven-year study of endoscopic sclerotherapy. Dig Dis Sci. 1991;36: 303-309.
8. Watanabe K, Kimura K, Matsutani S, et al. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology. 1988;95:434-440.
9. Polio J, Groszmann RJ. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis. 1986;6:318-331.
10. Kim T, Shijo H, Kokawa H, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997; 25:307-312.
11. Tan PC, Hou MC, Lin HC, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology. 2006;43:690-697.
12. Paik CN, Kim SW, Lee IS, et al. The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome. J Clin Gastroenterol. 2008;42:916-922.
13. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007;102:2086-2102.
14. Hosking SW, Johnson AG. Gastric varices: a proposed classification leading to management. Br J Surg. 1988;75: 195-196.
15. Hashizume M, Kitano S, Yamaga H, et al. Endoscopic classification of gastric varices. Gastrointest Endosc. 1990; 36:276-280.
16. Kravetz D, Sikuler E, Groszmann RJ. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution. Gastroenterology. 1986;90:1232-1240.
17. Castaneda B, Morales J, Lionetti R, et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology. 2001;33: 821-825.
18. Bernard B, Cadranel JF, Valla D, et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108:1828-1834.
19. Goulis J, Armonis A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998;27:1207-1212.
20. Bernard B, Grange JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a metaanalysis. Hepatology. 1999;29:1655-1661.
21. Soares-Weiser K, Brezis M, Tur-Kaspa R, et al. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding (Cochrane Review). Cochrane (library) 2002;2:CD002907.
22. Llovet JM, Rodriguez-Iglesias P, Moitinho E, et al. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol. 1997; 26:88-95.
23. Fernandez J, Navasa M, Gomez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140-148.
24. Ferná ndez J, Ruiz del Arbol L, Gó mez C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131:1049-1056.
25. Banares R, Albillos A, Rincon D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35: 609-615.
26. Damico G, Criscuoli V, Fili D, et al. Meta-analysis of trials for variceal bleeding. Hepatology. 2002;36:1023.
27. Teré s J, Cecilia A, Bordas JM, et al. Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken- Blakemore tube and the Linton-Nachlas tube. Gastroenterology. 1978;75:566-569.
28. Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc. 1997;46: 8-14.
29. Bretagne JF, Dudicourt JC, Morisot D, et al. Is endoscopic variceal sclerotherapy effective for the treatment of gastric varices? [abstract] Dig Dis Sci. 1986;31:505S.
30. Gimson AE, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage. J Hepatol. 1991;13:274-278.
31. Hsu PI, Lai KH, Lin CK, et al. A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol. 2005;100:2387-2392.
32. Sarin SK, Jain AK, Jain M, et al. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol. 2002;97: 1010-1015.
33. Schuman BM, Beckman JW, Tedesco FJ, et al. Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol. 1987;82:823-830.
34. Shiha G, El-Sayed SS. Gastric variceal ligation: a new technique. Gastrointest Endosc. 1999;49:437-441.
35. Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33:1060-1064.
36. Cipolletta L, Bianco MA, Rotondano G, et al. Emergency endoscopic ligation of actively bleeding gastric varices with a detachable snare. Gastrointest Endosc. 1998;47:400-403.
37. Lee MS, Cho JY, Cheon YK, et al. Use of detachable snares and elastic bands for endoscopic control of bleeding from large gastric varices. Gastrointest Endosc. 2002;56:83-88.
38. Chun HJ, Hyun JH. A new method of endoscopic variceal ligation-injection sclerotherapy (EVLIS) for gastric varices. Korean J Intern Med. 1995;10:108-119.
39. Yoshida T, Harada T, Shigemitsu T, et al. Endoscopic management of gastric varices using a detachable snare and simultaneous endoscopic sclerotherapy and O-ring ligation. J Gastroenterol Hepatol. 1999;14:730-735.
40. Arakaki Y, Murakami K, Takahashi K, et al. Clinical evaluation of combined endoscopic variceal ligation and sclerotherapy of gastric varices in liver cirrhosis. Endoscopy. 2003;35:940-945.
41. Bloomfield L. Working knowledge: instant glue. Sci Am. 1999;280:104.
42. Vinters HV, Galil KA, Lundie MJ, et al. The histotoxicity of cyanoacrylates. A selective review. Neuroradiology. 1985;27: 279-291.
43. Rengstorff DS, Binmoeller KF. A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans. Gastrointest Endosc. 2004;59:553-558.
44. Oho K, Iwao T, Sumino M, et al. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy. 1995;27:349-354.
45. Lunderquist A, Bö rjesson B, Owman T, et al. Isobutyl 2-cyanoacrylate (bucrylate) in obliteration of gastric coronary vein and esophageal varices. AJR Am J Roentgenol. 1978; 130:1-6.
46. Gotlib JP, Zimmermann P. Une nouvelle technique de traitment endoscopique des varices oesophageiennes: Lobliteration. Endos Dig. 1984;7:10-12.
47. Ogawa K, Ishikawa S, Naritaka Y, et al. Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding. J Gastroenterol Hepatol. 1999;14:245-250.
48. Cheng LF, Wang ZQ, Li CZ, et al. Treatment of gastric varices by endoscopic sclerotherapy using butyl cyanoacrylate: 10 years experience of 635 cases. Chin Med J (Engl). 2007;120:2081-2085.
49. Seewald S, Ang TL, Imazu H, et al. A standardized injection technique and regimen ensures success and safety of N-butyl- 2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointest Endosc. 2008;68:447-454.
50. Hou MC, Lin HC, Lee HS, et al. A randomized trial of endoscopic cyanoacrylate injection for acute gastric variceal bleeding: 0.5mL versus 1.0 mL. Gastrointest Endosc. 2009; 70:668-675.
51. Mumtaz K, Majid S, Shah H, et al. Prevalence of gastric varices and results of sclerotherapy with N-butyl 2 cyanoacrylate for controlling acute gastric variceal bleeding. World J Gastroenterol. 2007;13:1247-1251.
52. Marques P, Maluf-Filho F, Kumar A, et al. Long-term outcomes of acute gastric variceal bleeding in 48 patients following treatment with cyanoacrylate. Dig Dis Sci. 2008;53: 544-550.
53. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc. 2000;52:160-167.
54. Mahadeva S, Bellamy MC, Kessel D, et al. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol. 2003;98:2688-2693.
55. Procaccini NJ, Al-Osaimi AM, Northup P, et al. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc. 2009;70:881-887.
56. Lo GH, Liang HL, ChenWC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007;39:679-685.
57. Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23:1702-1709.
58. Cheng PN, Sheu BS, Chen CY, et al. Splenic infarction after histoacryl injection for bleeding gastric varices. Gastrointest Endosc. 1998;48:426-427.
59. Rosch W. UCTN: pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy. 1998;30:S89-S90.
60. Turler A, Wolff M, Dorlars D, et al. Embolic and septic complications after sclerotherapy of fundic varices with cyanoacrylate. Gastrointest Endosc. 2001;53:228-230.
61. Tan YM, Goh KL, Kamarulzaman A, et al. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002; 55:276-278.
62. Battaglia G, Morbin T, Patarnello E, et al. Visceral fistula as a complication of endoscopic treatment of esophageal and gastric varices using isobutyl-2-cyanoacrylate: report of 2 cases. Gastrointest Endosc. 2000;52:267-270.
63. Iwase H, Maeda O, Shimada M, et al. Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding. Gastrointest Endosc. 2001;53:585-592.
64. Daly PM. Use of buffer thrombin in treatment of gastric varices: a preliminary report. Arch Surg. 1947;55:208-212.
65. Kitano S, Hashizume M, Yamaga H, et al. Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial. Br J Surg. 1989;76:715-718.
66. Snobl J, Van Buuren HR, Van Blankenstein M. Endoscopic injection using thrombin: an effective and safe method for controlling oesophagogastric variceal bleeding. Gastroenterology. 1992;102:A891.
67. Williams SG, Peters RA, Westaby D. Thrombin-an effective treatment for gastric variceal haemorrhage. Gut. 1994;35: 1287-1289.
68. Przemioslo RT, McNair A, Williams R. Thrombin is effective in arresting bleeding from gastric variceal hemorrhage. Dig Dis Sci. 1999;44:778-781.
69. Heneghan MA, Byrne A, Harrison PM. An open pilot study of the effects of a human fibrin glue for endoscopic treatment of patients with acute bleeding from gastric varices. Gastrointest Endosc. 2002;56:422-426.
70. Yang WL, Tripathi D, Therapondos G, et al. Endoscopic use of human thrombin in bleeding gastric varices. Am J Gastroenterol. 2002;97:1381-1385.
71. Datta D, Vlavianos P, Alisa A, et al. Use of fibrin glue (beriplast) in the management of bleeding gastric varices. Endoscopy. 2003;35:675-678.
72. McAvoy NC, Hayes PC. The use of human thrombin for the treatment of gastric and ectopic varices. Gut. 2006;55:A5.
73. Ramesh J, Limdi JK, Sharma V, et al. The use of thrombin injections in the management of bleeding gastric varices: a single-center experience. Gastrointest Endosc. 2008;68:877-882.
74. Stanley AJ, Jalan R, Ireland HM, et al. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther. 1997;11:171-176.
75. Chau TN, Patch D, Chan YW, et al. Salvage transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology. 1998; 114:981-987.
76. Rees CJ, Nylander DL, Thompson NP, et al. Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment? Liver. 2000;20:253-256.
77. Tripathi D, Therapondos G, Jackson E, et al. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut. 2002;51:270-274.
78. Barange K, Péron JM, Imani K, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology. 1999;30: 1139-1143.
79. Song HG, Lee HC, Park YH, et al. Therapeutic efficacy of transjugular intrahepatic portosystemic shunt on bleeding gastric varices. Taehan Kan Hakhoe Chi. 2002;8:448-557.
80. Angermayr B, Cejna M, Koenig F, et al. Vienna TIPS Study Group. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stent grafts versus bare stents. Hepatology. 2003;38:1043-1050.
81. Garcia-Tsao G, Sanyal AJ, Grace ND et al. Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007;102:2086-2102.
82. Evrard S, Dumonceau JM, Delhaye M, et al. Endoscopic istoacryl obliteration versus propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy. 2003;35:729-735.
83. Wu CY, Yeh HZ, Chen GH. Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis. J Clin Gastroenterol. 2002;35:127-132.
84. Khan S, Tudur Smith C, Williamson P, et al. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Sys Rev. 2006; 4:CD000553.
85. Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117:626-631.
86. Kiyosue H, Matsumoto S, Yamada Y, et al. Transportal intravariceal sclerotherapy with N-butyl-2-cyanoacrylate for gastric varices. J Vasc Interv Radiol. 2004;15:505-509.
87. Kanagawa H, Mima S, Kouyama H, et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11:51-58.
88. Kitamoto M, Imamura M, Kamada K, et al. Balloonoccluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol. 2002;178: 1167-1174.
89. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12:327-236.
90. Ninoi T, Nishida N, Kaminou T, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol. 2005;184:1340-1346.
91. Cho SK, Shin SW, Lee IH, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol. 2007; 189:W365-W372.
92. Chikamori F, Kuniyoshi N, Kawashima T, et al. Gastric varices with gastrorenal shunt: combined therapy using transjugular retrograde obliteration and partial splenic embolization. AJR Am J Roentgenol. 2008;191:555-559.
93. Hong CH, Kim HJ, Park JH, et al. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2- cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 2009;24: 372-378.
94. Hirota S, Fukuda T, Matsumoto S, et al. Balloon-occluded retrograde transvenous obliteration (B-RTO) for portal hypertension. Nippon Igaku Hoshasen Gakkai Zasshi. 2000; 60:361-367.
95. Choi YH, Yoon CJ, Park JH, et al. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol. 2003;4:109-116.
96. Harned RK II, Thompson HR, Kumpe DA, et al. Partial splenic embolization in five children with hypersplenism: effects of reduced-volume embolization on efficacy and morbidity. Radiology. 1998;209:803-806.
97. Brandt CT, Rothbarth LJ, Kumpe D, et al. Splenic embolization in children: long-term efficacy. J Pediatr Surg. 1989;24:642-645.
98. Alwmark A, Bengmark S, Gullstrand P, et al. Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Ann Surg. 1982;196:518-524.
99. Kumpe DA, Rumack CM, Pretorius DH, et al. Partial splenic embolization in children with hypersplenism. Radiology. 1985;155:357-362.
100. N'Kontchou G, Seror O, Bourcier V, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance, and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17:179-184.
101. Spigos DG, Jonasson O, Mozes M, et al. Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol. 1979;132:777-782.
102. Murata K, Shiraki K, Takase K, et al. Long term follow-up for patients with liver cirrhosis after partial splenic embolization. Hepatogastroenterology. 1996;43:1212-1217.
103. Shah R, Hossein Mahour G, Ford EG, et al. Partial splenic embolization, an effective alternative to splenectomy for hypersplenism. Am Surg. 1990;56:774-777.
104. Whipple AO. The problem of portal hypertension in relation to the hepatosplenopathies. Ann Surg. 1945;122:449-456.
105. Orozco H, Mercado MA. The evolution of portal hypertension surgery: lessons from 1000 operations and 50 Years experience. Arch Surg. 2000;135:1389-1393.
106. Warren WD, Zeppa R, Foman JS. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunts. Ann Surg. 1967;166:437.
107. Sugiura M, Futagawa S. Esophageal transection with paraesophagogastric devascularization (Sugiura procedure) in the treatment of esophageal varices. World J Surg. 1984;8:673.
108. Kö klü S, Coban S, Yü ksel O, et al. Left-sided portal hypertension. Dig Dis Sci. 2007;52:1141-1149.
109. Tsuchida S, Ku Y, Fukumoto T, et al. Isolated gastric varices resulting from iatrogenic splenic vein occlusion: report of a case. Surg Today. 2003;33:542-544.
110. Bismuth H, Adam R, Raccuia JS. Liver transplantation in the treatment strategy of portal hypertension. Chirurg. 1995;66: 574-581.
111. Shaked A, Goldstein RM, Klintmalm GB, et al. Portosystemic shunt versus orthotopic liver transplantation for the Budd- Chiari syndrome. Surg Gynecol Obstet. 1992;174:453-459.
112. Choudhuri G, Dhiman RK, Agarwal DK. Endosonographic evaluation of the venous anatomy around the gastroesophageal junction in patients with portal hypertension. Hepatogastroenterology. 1996;43:1250-1255.
113. Konishi Y, Nakamura T, Kida H, et al. Catheter US probe EUS evaluation of gastric cardia and perigastric vascular structures to predict esophageal variceal recurrence. Gastrointest Endosc. 2002;55:197-203.
114. Iwase H, Suga S, Morise K, et al. Color Doppler endoscopic ultrasonography for the evaluation of gastric varices and endoscopic obliteration with cyanoacrylate glue. Gastrointest Endosc. 1995;41:150-154.
115. Lee YT, Chan FK, Ng EK, et al. EUS-guided injection of cyanoacrylate for bleeding gastric varices. Gastrointest Endosc. 2000;52:168-174.
116. Romero-Castro R, Pellicer-Bautista FJ, Jimenez-Saenz M, et al. EUS-guided injection of cyanoacrylate in perforating feeding veins in gastric varices: results in 5 cases. Gastrointest Endosc. 2007;66:402-407.
117. Mishra S, Sharma B, Kumar A, et al. Primary prophylaxis of gastric variceal bleed comparing cyanoacrylate injection and beta-blockers. J Hepatol. 2009;50:403A.
118. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167-176.
119. Pauwels A, Mostefa-Kara N, Debenes B, et al. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology. 1996;24:802-806.
120. Blaise M, Pateron D, Trinchet JC, et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1994; 20:34-38.
121. Battaglia G, Bocus P, Morbin T, et al. Endoscopic Doppler US-guided injection therapy for gastric varices: case report. Gastrointest Endosc. 2003;57:608-611.
122. Lo GH, Lai KH, Cheng JS, et al. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy. Gastrointest Endosc. 1999;49:428-436.